All Stories

  1. Exosomal miR-224-3p promotes lymphangiogenesis and lymph node metastasis by targeting GSK3B in gastric cancer

    Article • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, January 2025, Tsinghua University Press

    Yiran Si

  2. Gastric cancer secreted miR-214-3p inhibits the anti-angiogenesis effect of apatinib by suppressing ferroptosis in vascular endothelial cells

    Article • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, January 2024, Tsinghua University Press

    Yiran Si

  3. Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer

    Article • Cancer Biology and Medicine, December 2023, Tsinghua University Press

    Yiran Si

  4. Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C/EPBβ

    Article • Cancer Biology and Medicine, February 2022, Tsinghua University Press

    Yiran Si

  5. Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma

    Article • Cancer Biology and Medicine, January 2022, Tsinghua University Press

    Yiran Si

  6. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules

    Article • Disease Markers, September 2019, Hindawi Publishing Corporation

    Yiran Si

  7. Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy

    Article • Current Cancer Drug Targets, April 2018, Bentham Science Publishers

    Yiran Si

  8. miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer

    Article • Tumor Biology, June 2017, SAGE Publications

    Yiran Si

  9. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha acts as a tumor suppressor in hepatocellular carcinoma

    Article • Tumor Biology, April 2017, SAGE Publications

    Yiran Si

  10. miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma

    Article • Cellular Physiology and Biochemistry, January 2017, Karger Publishers

    Yiran Si